Clinical Trial Update: Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy [NA]

View source ↗

Summary

A clinical trial evaluating tumor control in prostate cancer using dose intensification to the dominant intra-prostatic lesion with ultra-hypofractionated, MR-g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | NA | Status: RECRUITING